Research Topic · Peer-Reviewed

Cancer Pharmacogenetics

Cancer pharmacogenetics is the field of study that involves understanding how genes affect a person's response to cancer treatment. It focuses on the role of genes in how cancer patients respond to drugs and other therapies. Through this research, physicians and scientists are able to develop personalized treatments…

📚 0 peer-reviewed articles cited 🔖 ISSN 2572-3030 🗓 Reviewed July 2026

Overview

Cancer pharmacogenetics is the field of study that involves understanding how genes affect a person's response to cancer treatment. It focuses on the role of genes in how cancer patients respond to drugs and other therapies. Through this research, physicians and scientists are able to develop personalized treatments for cancer patients based on their individual genetic profiles, allowing for more effective and safer cancer treatments. By understanding how a person’s genes affect their response to cancer drugs, clinicians are able to choose the most effective therapy while avoiding the potential side effects associated with a drug. Developments in this area have the potential to improve cancer outcomes and have a significant impact on patient care.

Research published in this journal

No peer-reviewed research on this exact topic has been published in Cancer Genetics And Biomarkers yet. Browse the journal →

Editorial oversight

Curated from peer-reviewed research published in Cancer Genetics And Biomarkers (ISSN 2572-3030).

Journal editorial board
Dr. Charlie Gourley · United Kingdom Dr. Xinyu Chen · United States Dr. Guru Prasad Maiti · United States

This page summarises published research for orientation; it is not medical or professional advice.